FDA Approves Twice-Yearly Injectable to Prevent HIV
The FDA has approved a first ever twice-yearly injectable regimen for HIV prevention in adults and adolescents, offering an effective alternative to daily PrEP.
More Videos
How Lockheed Martin Is Ramping Up Missile Production at Record Speed
This Memorial Day, Tim Cahill of Lockheed Martin explains the future of THAAD systems and U.S. defense manufacturing.
Inside Nvidia’s Record Quarter and the Global AI Arms Race
Ray Wang of Constellation Research breaks down Nvidia’s blockbuster earnings and the future of the AI chip race.
How Xometry Is Transforming the Future of Manufacturing
Randy Altschuler, CEO of Xometry, discusses AI, automation and the rise of on-demand manufacturing.
The Billion-Dollar AI Breakup: Inside Musk’s Failed War Against OpenAI
Andrew Nusca, Editorial Director at Fortune, breaks down how Musk’s failed $150 billion lawsuit could reshape AI governance.
SpaceX, OpenAI and Anthropic Set the Stage for an IPO Frenzy
Jim Neesen of Connor Group discusses the AI-driven IPO boom, SpaceX, OpenAI, Anthropic and whether Wall Street can sustain the hype.
Why the Beijing Summit Could Reshape the Future of AI
Politico’s Aaron Mak breaks down the Trump-Xi Beijing summit, AI competition, semiconductor tensions and what it means for global tech.
